Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Alterations and test-retest reliability of functional connectivity network measures in cerebral small vessel disease.

Gesierich B, Tuladhar AM, Ter Telgte A, Wiegertjes K, Konieczny MJ, Finsterwalder S, Hübner M, Pirpamer L, Koini M, Abdulkadir A, Franzmeier N, Norris DG, Marques JP, Zu Eulenburg P, Ewers M, Schmidt R, de Leeuw FE, Duering M.

Hum Brain Mapp. 2020 Feb 22. doi: 10.1002/hbm.24967. [Epub ahead of print]

PMID:
32087047
2.

Minor gait impairment despite white matter damage in pure small vessel disease.

Finsterwalder S, Wuehr M, Gesierich B, Dietze A, Konieczny MJ, Schmidt R, Schniepp R, Duering M.

Ann Clin Transl Neurol. 2019 Oct;6(10):2026-2036. doi: 10.1002/acn3.50891. Epub 2019 Sep 16.

3.

Prognostic relevance of cortical superficial siderosis in cerebral amyloid angiopathy.

Wollenweber FA, Opherk C, Zedde M, Catak C, Malik R, Duering M, Konieczny MJ, Pascarella R, Samões R, Correia M, Martí-Fàbregas J, Linn J, Dichgans M.

Neurology. 2019 Feb 19;92(8):e792-e801. doi: 10.1212/WNL.0000000000006956. Epub 2019 Jan 23.

PMID:
30674596
4.

Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden.

Duering M, Konieczny MJ, Tiedt S, Baykara E, Tuladhar AM, Leijsen EV, Lyrer P, Engelter ST, Gesierich B, Achmüller M, Barro C, Adam R, Ewers M, Dichgans M, Kuhle J, de Leeuw FE, Peters N.

J Stroke. 2018 May;20(2):228-238. doi: 10.5853/jos.2017.02565. Epub 2018 May 31.

5.

Free water determines diffusion alterations and clinical status in cerebral small vessel disease.

Duering M, Finsterwalder S, Baykara E, Tuladhar AM, Gesierich B, Konieczny MJ, Malik R, Franzmeier N, Ewers M, Jouvent E, Biessels GJ, Schmidt R, de Leeuw FE, Pasternak O, Dichgans M.

Alzheimers Dement. 2018 Jun;14(6):764-774. doi: 10.1016/j.jalz.2017.12.007. Epub 2018 Feb 16.

6.

Omental Approach to Functional Recovery After Cerebrovascular Disease.

Konieczny MJ, Ri SJ, Georgiadis JR.

World Neurosurg. 2016 Mar;87:406-16. doi: 10.1016/j.wneu.2015.10.024. Epub 2015 Oct 19. Review.

PMID:
26493716
7.

Dorsal root ganglion neurons carrying a P301S Tau mutation: a valid in vitro model for screening drugs against tauopathies?

Alberts N, Groen K, Klein L, Konieczny MJ, Koopman M.

J Neurosci. 2014 Apr 2;34(14):4757-9. doi: 10.1523/JNEUROSCI.0135-14.2014. No abstract available.

Supplemental Content

Loading ...
Support Center